The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

DHAC     4-amino-1-[(2R,3R,4S,5R)-3,4- dihydroxy-5...

Synonyms: SureCN14196, SureCN61544, DHAC cpd, AG-G-29537, LS-1500, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of AIDS027578


High impact information on AIDS027578


Chemical compound and disease context of AIDS027578


Biological context of AIDS027578


Analytical, diagnostic and therapeutic context of AIDS027578


  1. Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma. Carr, B.I., Rahbar, S., Doroshow, J.H., Blayney, D., Goldberg, D., Leong, L., Asmeron, Y. Cancer Res. (1987) [Pubmed]
  2. The comparative effects of 5-azacytidine and dihydro-5-azacytidine on polysomal RNA in Ehrlich ascites cells in vitro. Lin, H.L., Glazer, R.I. Mol. Pharmacol. (1981) [Pubmed]
  3. Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma. Dhingra, H.M., Murphy, W.K., Winn, R.J., Raber, M.N., Hong, W.K. Investigational new drugs. (1991) [Pubmed]
  4. Effects of dihydro-5-azacytidine on cell survival and cell cycle progression of cultured mammalian cells. Traganos, F., Staiano-Coico, L., Darzynkiewicz, Z., Melamed, M.R. Cancer Res. (1981) [Pubmed]
  5. The effect of 5-azacytidine and dihydro-5-azacytidine on nuclear ribosomal RNA and poly(A) RNA synthesis in L1210 cells in vitro. Glazer, R.I., Peale, A.L., Beisler, J.A., Abbasi, M.M. Mol. Pharmacol. (1980) [Pubmed]
  6. Plasma kinetics and effects of 5,6-dihydro-5-azacytidine in mice and L1210 tumor. Zaharko, D.S., Covey, J.M., Kelley, J.A. Investigational new drugs. (1985) [Pubmed]
  7. Studies on the cytostatic action, phosphorylation and deamination of 5-azacytidine and 5,6-dihydro-5-azacytidine in HeLa cells. Futterman, B., Derr, J., Beisler, J.A., Abbasi, M.M., Voytek, P. Biochem. Pharmacol. (1978) [Pubmed]
  8. Cellular metabolism of 5,6-dihydro-5-azacytidine and its incorporation into DNA and RNA of human lymphoid cells CEM/O and CEM/dCk(-). Avramis, V.I., Powell, W.C., Mecum, R.A. Cancer Chemother. Pharmacol. (1989) [Pubmed]
  9. Inactivation of p16INK4a expression in malignant mesothelioma by methylation. Wong, L., Zhou, J., Anderson, D., Kratzke, R.A. Lung Cancer (2002) [Pubmed]
  10. A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma. Creagan, E.T., Schaid, D.J., Hartmann, L.C., Loprinzi, C.L. Am. J. Clin. Oncol. (1993) [Pubmed]
  11. Biochemical pharmacology and DNA methylation studies of arabinosyl 5-azacytidine and 5,6-dihydro-5-azacytidine in two human leukemia cell lines PER-145 and PER-163. Kees, U.R., Avramis, V.I. Anticancer Drugs (1995) [Pubmed]
  12. Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B. Yogelzang, N.J., Herndon, J.E., Cirrincione, C., Harmon, D.C., Antman, K.H., Corson, J.M., Suzuki, Y., Citron, M.L., Green, M.R. Cancer (1997) [Pubmed]
WikiGenes - Universities